1. Medtech Insight
  3. >>Europe

Will Industry Succeed Now In Thrusting Comprehensive Reform Medtech Regulations To Top Of EU Agenda?

 
• By Amanda Maxwell

It is no secret that there are significant problems in the implementation of the EU’s medtech regulations. But will EU regulators concede to industry’s latest lobbying efforts for fundamental change and accept this challenge as a starting point for discussions?

Loud & Clear
EU Medtech Industry's Lobbying Efforts Are Not Going Away • Source: Shutterstock

Structural issues in the EU’s medtech regulatory system make it slow, unpredictable, costly and complex, and lacking in agile pathways for innovation. They cannot be solved through the implementation of the Medical Device Regulation and the IVD Regulation alone.

For this reason, urgent and comprehensive

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

Thousands Of Cardiac Digital Twins Reveal Novel Connections With Mental Health

 
• By Natasha Barrow

King’s College London, Imperial College London and The Alan Turing Institute constructed cardiac digital twins at scale, creating over 3,400, in a new study using UK Biobank data published in Nature Cardiovascular Research on 16 May.

LSX Europe: Women’s Health Education Is The Key For Unlocking VC Investment

 
• By Natasha Barrow

Flo Health was the first femtech unicorn to be valued at over $1bn. But the company faced 49 investment rejections before reaching that status, Anna Klepchukova, the company’s chief medical officer, told the LSX World Congress Europe. THENA Capital’s Esther Reynal de St Michel Richardot talked through the firm’s gender-smart investment strategy.

Abbott’s FreeStyle Libre CGM Reduces Cardiovascular Disease-Related Hospitalization

 
• By Natasha Barrow

The REFLECT studies showed a 78% reduction in cardiovascular disease-related hospitalization for people living with type 1 diabetes with prior low blood sugar episodes.

A Deregulated Medtech Sector Could Flourish In Merz’s Industry-Friendly Germany

 
• By Ashley Yeo

Less bureaucracy, no more national supply chain law, framework agreements and competition for direct reimbursement of medtech innovations are among the positive changes the local medtech industry might expect as Germany’s new government gets down to work. Life sciences lawyer Gunnar Sachs offers a view from the ground.

More from Geography